Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07161505 · ClinicalTrials.gov registry record · NA
Personalized Theta-burst Stimulation for Long-lasting Changes in Approach/Avoidance Behavior
A NA study of Approach/Avoidance Behavior, sponsored by Northwestern University.
- Recruiting
- Registry status
- NA
- Development phase
- 26
- Enrollment target
- 1
- Study location
NCT07161505: Recruiting NA study of Approach/Avoidance Behavior, sponsored by Northwestern University.
NCT07161505 is a NA study of Approach/Avoidance Behavior that is actively recruiting participants, run by Northwestern University. The registered enrollment target is 26 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07161505, a NA study of Approach/Avoidance Behavior, is actively recruiting participants, sponsored by Northwestern University.
- RECRUITING
- Registry status
- NA
- Development phase
- 26 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will assess the long-lasting effects of personalized theta burst stimulation (TBS), a repetitive form of transcranial magnetic stimulation (TMS), over the left prefrontal cortex on the approach/avoidance behavior. TBS will be personalized based on the prefrontal theta rhythm captured with electroencephalography (EEG). The main questions it aims to answer are: 1. does a single session of personalized TBS synchronized with the individual theta rhythm over the left prefrontal cortex results in the outlasting changes in the individual behavior? 2. Does TBS results in the brain rhythms' changes as measured using resting-state EEG?
Primary Outcome
The changes in the reaction times (post-stimulation relative to pre-stimulation) for the correct responses in the approach/avoidance test.
Conditions Studied
Interventions
- DEVICE TBS-EEG
- DEVICE TBS-EEG / Spatial Control
- DEVICE TBS / Temporal Control
- DEVICE TBS-EEG / Dose Control
Study Locations (1)
Illinois
- Northwestern University Feinberg School of Medicine - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 26 participants |
| Start Date | 2025-07-31 |
| Est. Completion | 2026-08-31 |
| Phase | NA |
What NCT07161505 shows while recruiting
NCT07161505 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 26 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 1 condition, with Approach/Avoidance Behavior appearing as the primary indexed condition, and to 4 interventions - of which TBS-EEG is the first listed.
NCT07161505 reports a single indexed study location in Illinois.
Frequently Asked Questions
What is clinical trial NCT07161505 about?
NCT07161505 is a clinical study titled "Personalized Theta-burst Stimulation for Long-lasting Changes in Approach/Avoidance Behavior". This study will assess the long-lasting effects of personalized theta burst stimulation (TBS), a repetitive form of transcranial magnetic stimulation (TMS), over the left prefrontal cortex on the approach/avoidance behavior. TBS will be personalized based on the prefrontal theta rhythm captured with...
What is the current status of trial NCT07161505?
This trial is currently recruiting. It is a NA study. The enrollment target is 26 participants. The study started on 2025-07-31. Estimated completion is 2026-08-31.
What conditions does trial NCT07161505 study?
This clinical trial studies the following conditions: Approach/Avoidance Behavior.
What interventions are being tested in trial NCT07161505?
The interventions under investigation include: TBS-EEG (DEVICE), TBS-EEG / Spatial Control (DEVICE), TBS / Temporal Control (DEVICE), TBS-EEG / Dose Control (DEVICE).
Who is sponsoring clinical trial NCT07161505?
This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07161505 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07161505's enrollment target sits among peer trials
26 1710th of 2000 higher than 289 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02646475 · 26 participants · Phase 1
Metabolic Effects of Angiotensin-(1-7)
- NCT03603223 · 26 participants · Phase 2
Pembrolizumab in Treating Participants With Leukoplakia
- NCT04063592 · 26 participants · NA
AMI Construction in Lower Extremity Residual Limbs
- NCT04906460 · 26 participants · Phase 1
Open-label Study of WVE-N531 in Patients With Duchenne Muscular Dystrophy (FORWARD-53)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI